Chemical formula: C₂₈H₅₄GdN₅O₂₀ Molecular mass: 547.58 g/mol PubChem compound: 55466
Gadopentetate dimeglumine interacts in the following cases:
For gadopentetic acid, dimeglumine no clinical study data on exposed pregnancies are available. Animal studies do not indicate direct or indirect harmful effects with respect to embryonal/foetal development.
No data exist concerning intra-articular administration in lactating women. After intravascular use minimal amounts of gadopentetic acid, dimeglumine salt (a maximum of 0.04%) of the intravenously administered dose enters the breast milk. From experience gained so far, harm to the breast-fed infant is considered unlikely.
No effects of gadopentetic acid on driving ability and use of machinery can be expected. However, joint effusion may affect the ability to drive due to a limited joint mobility.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
